Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · IEX Real-Time Price · USD
8.86
+0.49 (5.85%)
At close: Jul 26, 2024, 4:00 PM
8.93
+0.07 (0.79%)
After-hours: Jul 26, 2024, 6:36 PM EDT

Acrivon Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Cash & Equivalents
24.6136.0229.5299.61.58
Short-Term Investments
85.3791.4498.23--
Cash & Short-Term Investments
109.98127.46127.7599.61.58
Cash Growth
-8.52%-0.23%28.26%6192.04%-
Prepaid Expenses
2.172.234.340.810.14
Total Current Assets
112.14129.69132.1100.411.72
Property, Plant & Equipment
7.617.916.865.790.06
Long-Term Investments
--41.88--
Long-Term Deferred Charges
0.350.25---
Other Long-Term Assets
0.420.410.390.390.41
Total Assets
120.52138.27181.23106.592.19
Accounts Payable
2.065.050.90.960.14
Accrued Expenses
5.97.384.141.220.42
Short-Term Debt
----0.06
Current Portion of Leases
0.940.880.730.66-
Current Unearned Revenue
--0.070.07-
Other Current Liabilities
0.14-0.67--
Total Current Liabilities
9.0413.36.522.910.61
Long-Term Leases
3.53.774.244.96-
Total Liabilities
12.5417.0710.757.880.61
Common Stock
0.020.020.0200
Additional Paid-In Capital
240.93237.68226.581.050.21
Retained Earnings
-132.91-116.42-56.03-24.87-8.62
Comprensive Income & Other
-0.07-0.08-0.1--
Total Common Equity
107.98121.2170.48-23.81-8.41
Shareholders' Equity
107.98121.2170.4898.711.57
Total Liabilities & Equity
120.52138.27181.23106.592.19
Total Debt
4.454.644.965.630.06
Net Cash (Debt)
105.53122.81122.7993.981.53
Net Cash Growth
-8.57%0.02%30.66%6062.30%-
Net Cash Per Share
4.745.5629.7953.901.06
Filing Date Shares Outstanding
30.8822.6421.921.771.43
Total Common Shares Outstanding
22.6422.5221.921.771.43
Working Capital
103.1116.39125.5897.491.11
Book Value Per Share
4.775.387.78-13.45-5.87
Tangible Book Value
107.98121.2170.48-23.81-8.41
Tangible Book Value Per Share
4.775.387.78-13.45-5.87
Machinery
4.593.132.510.350.08
Construction In Progress
-1.31---
Source: S&P Capital IQ. Standard template.